📰 Relapse Rate News
Relapse Rate News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Relapse Rate. Real-time updates on events, politics, business and more.
December 16, 2023
Takeda TSE4502NYSETAK today announced the European Medicines Agencys EMA Committee for Medicinal Products for Human Use CHMP has recommended the approval of HYQVIA Immune Globulin Infusion 10 Human with Recombinant Human Hyaluronidase in patients with chronic inflammatory demyelinating polyneuropathy CIDP as maintenance therapy after stabilization with intravenous immunoglobulin therapy IVIG.
December 16, 2023
If Approved, HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] Would Offer an up to Once-Monthly Facilitated Subcutaneous…
June 21, 2023
TakedaTSE4502NYSETAK today announced full results from the pivotal Phase 3 ADVANCECIDP 1 clinical trial investigating HYQVIA Immune Globulin Infusion 10 Human with Recombinant Human Hyaluronidase as maintenance therapy in adult patients with chronic inflammatory demyelinating polyneuropathy CIDP.
December 29, 2022
TG Therapeutics Announces FDA Approval of BRIUMVI™ (ublituximab-xiiy) - read this article along with other careers information, tips and advice on BioSpace
December 28, 2022
BRIUMVI is the first and only anti-CD20 monoclonal antibody approved for patients with relapsing forms of multiple sclerosis that can be administered in a...
April 22, 2022
Whenever volatility is due to the larger market condition, your stock will most likely rebound to surpass their former high. See what this means for TGTX stock.
April 5, 2022
Cbs dr. jon lapook takes a look. >> reporter: tackling the opioid crisis requires changing strategies and the way we think about addiction says columbia professor sandra comer. >> one of the mistakes that people make when they think about drug users, "oh, its somebodys choice to have this disorder." it-- thats not true. >> reporter: its a medical disease. >> its a medical disease. an we need to treat it. >> reporter: 100,000 people died from drug overdose over the 12 months ending in may 2021. u...
March 4, 2022
TG Therapeutics Announces Data Presentations from the ULTIMATE I & II Phase 3 Trials of Ublituximab in Multiple Sclerosis to be Presented at the American Academy of Neurology Annual Meeting - read this article along with other careers information, tips and advice on BioSpace
August 10, 2021
PressNetwork – Presseportal für Pressemitteilungen und Unternehmens-News
August 23, 2019
Thats happening from the white house? >> i dont think that particular program is. i think that was something that was sort of more organic and born locally. but there have been various efforts by the trump administration, by others to get more programs like this. they used to be much more punitive. you know, they would want to punish these folks that tried to overdose. now theyre saying, lets try to help you. lets bring social workers in and stick with you. i was in ohio where they did a program...